Intent to Sole Source FDA-75F40126Q00155.pdf
PDF 284 KB Posted
- Attached to
- INTENT TO SOLE SOURCE gPROMS Lyophilization Modeling Toolbox (or equal) Federal contract opportunity
- Solicitation number
- FDA75F40126Q00155
About this file
This is an Intent to Sole Source notice for a lyophilization modeling software platform. The FDA's Center for Drug Evaluation and Research (CDER), Office of Pharmaceutical Quality Research (OPQR) intends to award a sole-source, Firm Fixed Price Purchase Order to Siemens Government Technologies, Inc. (2231 Crystal Dr, Suite 700, Arlington, Virginia 22202-3724) for a 12-month period of performance under FAR 6.302-1 authority. The solicitation number is FDA – 75F40126Q00155, classified under DH10 (IT and Telecom – Platform As A Service) with NAICS code 513210 (Software Publishers).
The required deliverable is the gPROMS Lyophilization Modeling Toolbox for 1 user for 12 months, which includes software licensing key, user manuals in digital format (CD, DVD, or download), and all associated materials. The toolbox must feature nonlinear predictive control for lyophilization with HPC-optimized architecture, operational intelligence and data integration capabilities (including Digital Twin validation support), high-fidelity dynamic simulation for freezing and drying phases, advanced thermodynamic property modeling for complex pharmaceutical formulations, automated Global System Analysis for parameter estimation and Quality by Design validation, customizable modeling environment with API integration (Python, Excel, Electronic Lab Notebooks), and scalable enterprise access with flexible licensing. The contractor must provide email and web conference support, maintenance and system upgrades, one day of project support, and access to online training materials via Altair resources. The response deadline for capability statements from interested parties is June 2, 2026, at 1:00 PM EST, directed to Terina Hicks at terina.hicks@fda.hhs.gov. If no responsive capability statements are received by the closing date, the award will be made to Siemens Government Technologies, Inc.
View the file
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
INTENT TO SOLE SOURCE
gPROMS Lyophilization Modeling Toolbox (or equal)
FDA – 75F40126Q00155
Date Posted: May 22, 2026
Response Date: June 2, 2026, 1:00 PM EST
Classification Code: DH10 – IT and Telecom – Platform As A Service: Database, Mainframe, Middleware
NAICS Code: 513210 – Software Publishers
The United States (US) Food and Drug Administration (FDA) intends to award a sole source, Firm Fixed
Price Purchase Order to Siemens Government Technologies, Inc., 2231 Crystal Dr, Suite 700, Arlington, Virginia 22202-3724, on a sole source base, under the authority of FAR 6.302-1, Only One Responsible
Source and No Other Supplies or Services Will Satisfy Agency Requirements.
The FDA / Center for Drug Evaluation and Research (CDER) / Office of Pharmaceutical Quality Research
(OPQR) requires to obtain an advanced lyophilization process modeling and simulation platform to study emerging pharmaceutical manufacturing technologies. This will be a 12-month period of performance for software license and support services.
The contractor shall provide the following salient characteristics:
Lyophilization Modeling Toolbox
• Nonlinear Predictive Control (NL) for Lyophilization: Utilizes a highly parallelized, equation-oriented architecture optimized for high-performance computing (HPC) to perform large-scale, high-fidelity predictive modeling of time-dependent lyophilization cycles.
• Operational Intelligence & Data Integration: Must include a base system (such as XHQ) capable of aggregating and visualizing real-time operational data from multiple manufacturing sources to support "Digital Twin" validation.
• High-Fidelity Dynamic Simulation: Capable of simulating transient process events and complex equipment dynamics—including freezing, primary drying, and secondary drying—using first-principles mathematical equations rather than empirical data.
• Advanced Material & Thermodynamic Property Architecture: Supports the modeling of complex pharmaceutical formulations through comprehensive databases for excipients and APIs to track critical properties like moisture content and chemical purity throughout the stabilization process.
• Automated Global System Analysis (GSA): Built-in mathematical tools to perform parameter estimation from experimental data and Global Sensitivity Analysis (GSA) to identify influential process parameters and validate Quality by Design (QbD) design spaces.
• Customizable Modeling Environment & API: Features an open, equation-oriented language for creating custom first-principles models from scratch, complemented by a robust Application
Programming Interface (API) for integration with external data systems like Python, Excel, or
Electronic Lab Notebooks.
• Scalable Enterprise Access: Supports flexible licensing types including "Named User" for specific researchers and "Small System" base configurations to manage data exchange across physical or virtual assets.
• Regulatory-Grade Maintenance and Support: Provided through a multi-year subscription model that includes continuous software enhancement, technical support, and alignment with established
Licensed Software Designation Agreements (LSDA).
Maintenance and Technical Support
At minimum the contractor must:
• Provide support via email and/or web conference.
• Licenses shall include maintenance, support, and any upgrades necessary to maintain the system.
• Provide one day of project support.
Training
The Contractor shall provide:
• Access to online training material in Altair resources
Deliverables
Item No. Description Qty. Unit
Lyophilization Modeling
Toolbox for 1 user
Months
Software and licensing key, Software and User Manuals or equal to in a digital copy provided on a CD, DVD or digital download. CD, DVD and hard copies of deliverables shall not be required to be returned to the Contractor.
Based on these unique qualifications, Siemens Government Technologies, Inc. is the only source available to provide advanced lyophilization process modeling and simulation platform, maintenance, technical support, and training to the FDA/CDER/OPQR that is not available from any other vendor. The service required is available from only one responsible source and no other type of service will satisfy the agency’s requirement.
This notice is being published in accordance with Federal Acquisition Regulation (FAR) Part 5.101(a)(1) requiring the dissemination of information on proposed contract actions. This is a notice of intent to award a sole-source contract and is not a request for competitive proposals. The statutory authority for this sole-source procurement is FAR 6.302-1.
This notice of intent is not a request for competitive proposals. Interested parties that believes it can meet the requirement, may submit a capability statement to Terina Hicks at terina.hicks@fda.hhs.gov by June
2,2026, at 1:00 PM Eastern Standard Time (EST). A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. If no responsive statements mailto:terina.hicks@fda.hhs.gov are received before the closing date and time, an award will subsequently be made to Siemens Government
Technologies, Inc. No telephonic inquiries.
File details come from the government source that posted it. Updated .